Vegavero Choline Supplement | Liver Supplements* | Choline-Bitartrate, Phosphatidylcholine & Citicoline | 90 Capsules | NO Additives, Lab-Tested | Vegan

Show on Amazon

Offer

Price trend

Product description

  • UNIQUE COMPOSITION Choline comes in different forms which is why we decided to create a synergistic and unique blend of three choline forms L-Choline bitartrate, CDP-Choline, and Phosphatidylcholine. Even though the choline from the different forms performs the same actions in the body, all three also have distinct functions, which makes our product superior to choline capsules or tablets with only one choline form.
  • VEGAN & OPTIMALLY DOSED Choline is also a natural component of different foods. That is why our capsules provide 506 mg of choline to not go beyond the recommended daily dosage while still contributing to an adequate intake. Our choline supplement is vegan and thus an ideal alternative to other tablets with animal-based gelatine. Of course, it's free from additives and non-GMO. Per bottle 90 capsules. Recommended dosage 2 capsules per day with plenty of water.
  • VEGAVERO CLASSIC Our Classic line is defined by high-quality vegan supplements that cover a wide range of essential nutrients, plant extracts, vital mushrooms, and other functional ingredients. We focus primarily on individual ingredients and always avoid artificial additives like unnecessary fillers. Our Classic products are constantly tested and improved by our team based on the most recent scientific findings. Vegavero Classic - for us this means quality, safety, and practicality.
  • BY YOUR SIDE Caring for you is part of our philosophy. So, in addition to providing supplements designed for your needs, we work on unique formulas to achieve the perfect synergy of ingredients and dosages for you. If you have any queries, we are happy to advise and support you in your goals, and or provide you with the certifications of each product and to answer all your questions.

You might also be interested in these choline capsules.

© 2025 WHICH.ONE. ALL CONTENT IS SUBJECT TO OUR COPYRIGHT.